Efficacy of Pulmicort Turbuhaler Combined with Salbutamol in the Treatment of Children with Cough Variant Asthma

Hai-yan LIU,Wei HOU,Jing LI,Ying-chun TIE,Bo ZHONG,Ling WANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2017.06.018
2017-01-01
Abstract:Objective:To discuss the efficacy of Pulmicort Turbuhaler combined with salbutamol in the treatment of children with cough variant asthma.Methods:100 patients with cough variant asthma were selected and divided into two groups.The salbutamol group (48 cases) were given salbutamol,and the combination group(52 cases) were given salbutamol and Pulmicort Turbuhaler.The efficacy of Pulmicort Turbuhaler combined with salbutamol in the treatment of children with cough variant asthma were evaluated by efficacy,cough relief and disappearance time,FVC,FEV1,PEF,MMEF and adverse reactions during 1 month follow-up.Results:After treatment,the efficiency of combination group was higher than that of the salbutamol group.The cough symptoms disappeared within 2 weeks in 92.3 % patients of combination group and 72.9 % cases in combination group.After treatment,the cough relief and disappearance time of combination group was shorter than that of the salbutamol group (P<0.05).There were no statistical significance on FVC,FEV1,PEF between two groups (P>0.05).Before treatment,the MMEF of two groups were lower than that of the healthy children (P<0.05).Compared with the healthy children,the other lung function indexes of two groups were not statistically significant (P>0.05).After treatment,the MMEF of combination group was higher than the value before treatment and the value in the salbutamol group (P<0.05).During 1 month follow-up,there were no statistical significance in the incidence of adverse reactions between two groups (P>0.05).Conclusions:Pulmicort Turbuhaler combined with salbutamol have good effect on CVA,which can shorten the disappearance time of cough symptoms and improve the pulmonary function of children,worthy of clinical use.
What problem does this paper attempt to address?